Real-World Outcomes of Combination Anthracycline and Taxane Adjuvant Therapies in Early Triple-Negative Breast Cancer: A Moroccan Retrospective Analysis
PURPOSENeoadjuvant chemoimmunotherapy followed by adjuvant immunotherapy is the gold standard for treating patients with higher risk early triple-negative breast cancer (TNBC); however, in some cases, these patients undergo surgery followed by chemotherapy-based anthracyclines and taxanes without ad...
Saved in:
| Main Authors: | Hassan Abdelilah Tafenzi, Farah Choulli, Ismail Essaadi, Rhizlane Belbaraka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2025-05-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO-24-00650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study
by: Hassan Abdelilah Tafenzi, et al.
Published: (2025-05-01) -
Digital Oncology in Morocco: Embracing Artificial Intelligence in a New Era
by: Hassan Abdelilah Tafenzi, et al.
Published: (2025-04-01) -
Effects of taxane-anthracycline and taxane only treatment on cardiac function in breast cancer—a retrospective cohort study
by: Árpád Kézdi, et al.
Published: (2025-04-01) -
Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
by: Yuhan Wei, et al.
Published: (2025-01-01) -
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)